Subsequently, Palumbo et al. conducted a comparative study of AD patients and healthy controls to measure concentrations of NSE, Aβ42, and T-Tau in CSF, finding a significant increase in NSE and T-Tau and a significant decrease in Aβ42. This evidence concerns the gene MAPT and Alzheimer disease.